source
- Swedish biotech AnaCardio secures $70.9M Series B to advance heart failure drugSwedish biotech AnaCardio announced a Series B financing round that raised €62.5 million ($70.9 million). The capital will be used to move its chronic advanced heart failure drug toward registrati…
- BioNTech to shut three German manufacturing sites after sale talks fall throughBioNTech announced it will close three of its manufacturing facilities in Germany. The decision follows months of searching for buyers for the sites. The company said it was unable to secure a dea…